There have been 50 recent insider transactions recorded for enVVeno Medical Corporation (NVNO), including 39 buys and 10 sells. Total insider buying was valued at $5.39M and total insider selling at $59.26K.
Notable insiders with recent activity include Duhay Francis, Berman Robert Andrew, Glickman Marc H.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NVNO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-12 |
Duhay Francis |
Director |
Informative Sell |
140 |
$11.52 |
$1.61K |
2,502 |
| 2025-12-16 |
Berman Robert Andrew |
Chief Executive Officer |
Other (Sell) |
200,000 |
- |
- |
- |
| 2025-12-16 |
Glickman Marc H. |
SVP & Chief Medical Officer |
Other (Sell) |
100,000 |
- |
- |
- |
| 2025-12-16 |
Alavi Hamed |
Chief Technology Officer |
Other (Sell) |
50,000 |
- |
- |
- |
| 2025-12-11 |
Duhay Francis |
Director |
Informative Sell |
4,900 |
$0.36 |
$1.74K |
92,544 |
| 2025-12-11 |
Jenusaitis Matthew |
Director |
RSU Award |
135,883 |
$0.33 |
$44.16K |
135,883 |
| 2025-12-11 |
Shrivastava Sanjay |
Director |
RSU Award |
135,883 |
$0.33 |
$44.16K |
135,883 |
| 2025-12-11 |
Duhay Francis |
Director |
RSU Award |
135,883 |
$0.33 |
$44.16K |
135,883 |
| 2025-12-11 |
Gray Robert |
Director |
RSU Award |
135,883 |
$0.33 |
$44.16K |
135,883 |
| 2025-09-15 |
Duhay Francis |
Director |
Informative Sell |
4,900 |
$0.83 |
$4.07K |
97,444 |
| 2025-05-19 |
Bright Jennifer |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-05-19 |
Bright Jennifer |
Chief Financial Officer |
RSU Award |
350,000 |
$3.62 |
$1.27M |
350,000 |
| 2024-12-31 |
Gray Robert |
Director |
Informative Buy |
3,500 |
$2.94 |
$10.29K |
11,155 |
| 2024-12-31 |
Duhay Francis |
Director |
Informative Buy |
81,433 |
$3.07 |
$250K |
102,344 |
| 2024-12-24 |
Shrivastava Sanjay |
Director |
Informative Buy |
5,400 |
$2.90 |
$15.66K |
9,288 |
| 2024-12-19 |
Berman Robert Andrew |
Chief Executive Officer |
Informative Buy |
12,000 |
$2.55 |
$30.6K |
222,236 |
| 2024-12-19 |
Jenusaitis Matthew |
Director |
Informative Buy |
9,620 |
$2.53 |
$24.34K |
16,545 |
| 2024-12-18 |
Berman Robert Andrew |
Chief Executive Officer |
RSU Award |
200,000 |
$2.57 |
$514K |
200,000 |
| 2024-12-18 |
Jenusaitis Matthew |
Director |
RSU Award |
19,752 |
$2.57 |
$50.76K |
19,752 |
| 2024-12-18 |
Glickman Marc H. |
SVP & Chief Medical Officer |
RSU Award |
75,000 |
$2.57 |
$192.75K |
75,000 |
| 2024-12-18 |
Shrivastava Sanjay |
Director |
RSU Award |
19,752 |
$2.57 |
$50.76K |
19,752 |
| 2024-12-18 |
Duhay Francis |
Director |
RSU Award |
19,752 |
$2.57 |
$50.76K |
19,752 |
| 2024-12-18 |
Gray Robert |
Director |
RSU Award |
19,752 |
$2.57 |
$50.76K |
19,752 |
| 2024-12-18 |
Alavi Hamed |
Chief Technology Officer |
RSU Award |
75,000 |
$2.57 |
$192.75K |
75,000 |
| 2024-03-13 |
Alavi Hamed |
Chief Technology Officer |
Informative Sell |
8,334 |
$6.22 |
$51.84K |
- |
| 2023-12-05 |
Berman Robert Andrew |
Chief Executive Officer |
RSU Award |
300,000 |
$3.59 |
$1.08M |
300,000 |
| 2023-12-05 |
Jenusaitis Matthew |
Director |
RSU Award |
13,856 |
$3.59 |
$49.74K |
13,856 |
| 2023-12-05 |
Glickman Marc H. |
SVP & Chief Medical Officer |
RSU Award |
100,000 |
$3.59 |
$359K |
100,000 |
| 2023-12-05 |
Shrivastava Sanjay |
Director |
RSU Award |
13,856 |
$3.59 |
$49.74K |
13,856 |
| 2023-12-05 |
Duhay Francis |
Director |
RSU Award |
13,856 |
$3.59 |
$49.74K |
13,856 |
| 2023-12-05 |
Gray Robert |
Director |
RSU Award |
13,856 |
$3.59 |
$49.74K |
13,856 |
| 2023-12-05 |
Glynn Craig |
Chief Financial Officer |
RSU Award |
75,000 |
$3.59 |
$269.25K |
75,000 |
| 2023-12-05 |
Alavi Hamed |
Chief Technology Officer |
RSU Award |
100,000 |
$3.59 |
$359K |
100,000 |
| 2023-01-18 |
Alavi Hamed |
Chief Technology Officer |
Disposition |
50,000 |
- |
- |
- |
| 2022-11-30 |
Jenusaitis Matthew |
Director |
RSU Award |
8,403 |
- |
- |
8,403 |
| 2022-11-30 |
Shrivastava Sanjay |
Director |
RSU Award |
8,403 |
- |
- |
8,403 |
| 2022-11-30 |
Duhay Francis |
Director |
RSU Award |
8,403 |
- |
- |
8,403 |
| 2022-11-30 |
Gray Robert |
Director |
RSU Award |
8,403 |
- |
- |
8,403 |
| 2022-09-13 |
Jenusaitis Matthew |
Director |
Option Exercise (Sell) |
1,041 |
- |
- |
- |
| 2022-09-13 |
Gray Robert |
Director |
Option Exercise (Sell) |
1,041 |
- |
- |
- |
| 2022-08-16 |
Duhay Francis |
Director |
Informative Buy |
7,751 |
$6.14 |
$47.59K |
20,911 |
| 2022-06-30 |
Shrivastava Sanjay |
Director |
Informative Buy |
1,000 |
$3.85 |
$3.85K |
3,888 |
| 2022-06-27 |
Berman Robert Andrew |
Chief Executive Officer |
Informative Buy |
2,500 |
$3.80 |
$9.5K |
210,236 |
| 2021-11-30 |
Berman Robert Andrew |
Chief Executive Officer |
RSU Award |
200,000 |
- |
- |
207,736 |
| 2021-11-30 |
Jenusaitis Matthew |
Director |
RSU Award |
7,211 |
$6.70 |
$48.31K |
7,211 |
| 2021-11-30 |
Glickman Marc H. |
SVP & Chief Medical Officer |
RSU Award |
100,000 |
- |
- |
101,600 |
| 2021-11-30 |
Shrivastava Sanjay |
Director |
RSU Award |
7,211 |
$6.70 |
$48.31K |
7,211 |
| 2021-11-30 |
Duhay Francis |
Director |
RSU Award |
7,211 |
$6.70 |
$48.31K |
7,211 |
| 2021-11-30 |
Gray Robert |
Director |
RSU Award |
7,211 |
$6.70 |
$48.31K |
7,211 |
| 2021-11-30 |
Glynn Craig |
Chief Financial Officer |
RSU Award |
50,000 |
- |
- |
50,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
